Dabur India Ltd
Dabur India is one of the leading fast moving consumer goods (FMCG) players dealing in consumer care and food products.(Source : 202003 Annual Report Page No:280)
- Market Cap ₹ 99,582 Cr.
- Current Price ₹ 562
- High / Low ₹ 611 / 482
- Stock P/E 69.6
- Book Value ₹ 34.2
- Dividend Yield 0.93 %
- ROCE 31.9 %
- ROE 25.5 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.2%
- Company has been maintaining a healthy dividend payout of 56.7%
Cons
- Stock is trading at 16.4 times its book value
- Promoter holding has decreased over last quarter: -1.00%
- The company has delivered a poor sales growth of 9.10% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,262 | 3,754 | 4,342 | 4,860 | 5,420 | 5,340 | 5,291 | 5,592 | 6,273 | 6,310 | 7,185 | 8,180 | 8,523 | |
2,628 | 3,097 | 3,619 | 4,034 | 4,480 | 4,242 | 4,178 | 4,360 | 4,906 | 4,927 | 5,626 | 6,445 | 6,807 | |
Operating Profit | 634 | 657 | 723 | 826 | 940 | 1,098 | 1,112 | 1,232 | 1,367 | 1,383 | 1,559 | 1,734 | 1,716 |
OPM % | 19% | 18% | 17% | 17% | 17% | 21% | 21% | 22% | 22% | 22% | 22% | 21% | 20% |
42 | 10 | 94 | 108 | 112 | 194 | 274 | 266 | 275 | 175 | 277 | 341 | 365 | |
Interest | 12 | 14 | 18 | 19 | 10 | 10 | 16 | 22 | 30 | 19 | 9 | 19 | 28 |
Depreciation | 68 | 66 | 49 | 54 | 66 | 73 | 75 | 102 | 109 | 130 | 143 | 160 | 172 |
Profit before tax | 596 | 587 | 750 | 861 | 977 | 1,209 | 1,294 | 1,373 | 1,503 | 1,408 | 1,683 | 1,896 | 1,881 |
Tax % | 21% | 21% | 21% | 22% | 22% | 22% | 23% | 22% | 16% | 17% | 18% | 24% | |
Net Profit | 471 | 463 | 591 | 672 | 763 | 937 | 998 | 1,072 | 1,264 | 1,170 | 1,382 | 1,433 | 1,431 |
EPS in Rs | 2.71 | 2.66 | 3.39 | 3.85 | 4.34 | 5.33 | 5.67 | 6.09 | 7.16 | 6.62 | 7.82 | 8.11 | 8.09 |
Dividend Payout % | 42% | 49% | 44% | 45% | 46% | 42% | 40% | 123% | 38% | 45% | 61% | 64% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 9% |
3 Years: | 9% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 7% |
3 Years: | 4% |
TTM: | -1% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 9% |
3 Years: | 5% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 30% |
5 Years: | 28% |
3 Years: | 27% |
Last Year: | 25% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
174 | 174 | 174 | 174 | 176 | 176 | 176 | 176 | 177 | 177 | 177 | 177 | 177 | |
Reserves | 927 | 1,129 | 1,391 | 1,728 | 2,161 | 2,918 | 3,482 | 4,051 | 3,792 | 4,398 | 5,214 | 5,687 | 5,877 |
257 | 273 | 242 | 44 | 129 | 87 | 284 | 287 | 310 | 151 | 180 | 560 | 502 | |
1,049 | 875 | 991 | 1,175 | 1,223 | 1,248 | 1,275 | 1,299 | 1,300 | 1,375 | 1,933 | 2,168 | 2,272 | |
Total Liabilities | 2,408 | 2,452 | 2,798 | 3,122 | 3,688 | 4,430 | 5,217 | 5,813 | 5,579 | 6,100 | 7,504 | 8,592 | 8,829 |
498 | 585 | 617 | 654 | 683 | 639 | 993 | 1,030 | 1,037 | 1,134 | 1,205 | 1,399 | 1,502 | |
CWIP | 4 | 12 | 17 | 17 | 12 | 25 | 28 | 27 | 22 | 106 | 107 | 128 | 93 |
Investments | 519 | 553 | 1,026 | 1,118 | 1,778 | 2,570 | 3,054 | 3,433 | 2,962 | 2,467 | 3,574 | 5,007 | 4,692 |
1,386 | 1,302 | 1,139 | 1,333 | 1,215 | 1,196 | 1,141 | 1,322 | 1,558 | 2,393 | 2,618 | 2,057 | 2,542 | |
Total Assets | 2,408 | 2,452 | 2,798 | 3,122 | 3,688 | 4,430 | 5,217 | 5,813 | 5,579 | 6,100 | 7,504 | 8,592 | 8,829 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
352 | 520 | 703 | 712 | 839 | 960 | 927 | 816 | 1,124 | 1,155 | 1,704 | 1,320 | |
-229 | -219 | -346 | -98 | -613 | -494 | -679 | -261 | 418 | -330 | -1,120 | -682 | |
-94 | -233 | -328 | -535 | -337 | -455 | -274 | -496 | -1,619 | -826 | -555 | -635 | |
Net Cash Flow | 28 | 69 | 29 | 79 | -111 | 11 | -26 | 59 | -78 | -2 | 29 | 3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 23 | 22 | 21 | 24 | 23 | 29 | 23 | 21 | 25 | 22 | 14 | 20 |
Inventory Days | 146 | 131 | 107 | 109 | 94 | 106 | 103 | 117 | 106 | 120 | 141 | 132 |
Days Payable | 157 | 129 | 123 | 137 | 130 | 160 | 157 | 159 | 145 | 153 | 187 | 169 |
Cash Conversion Cycle | 12 | 23 | 6 | -4 | -13 | -25 | -31 | -21 | -13 | -11 | -32 | -16 |
Working Capital Days | 12 | 13 | 0 | -5 | -4 | -1 | -7 | 1 | -8 | 0 | -17 | -10 |
ROCE % | 54% | 44% | 44% | 46% | 45% | 42% | 37% | 33% | 35% | 34% | 33% | 32% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19 Jan - Schedule of Investors'' Conference Call for Q3 FY 2022-23-Financial Results of Dabur India Limited pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
-
Publication Of Newspaper Notice For Loss Of Share Certificates
14 Jan - Enclose copies each of the Financial Express (English Daily) and Jansatta (Hindi Daily) both dated 14.01.2023 in which notice for intimation of loss of share …
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 11 Jan
- Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Update On Letter Dated 20.04.2022 11 Jan
-
Update On Letter Dated 05.12.2022
11 Jan - Update on letter dated 05.12.2022 - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Concalls
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
Jun 2022Transcript PPT
-
May 2022TranscriptPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Aug 2021TranscriptPPT
-
May 2021Transcript PPT
-
May 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Jul 2020Transcript PPT
-
May 2020TranscriptPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptPPT
-
Sep 2019TranscriptPPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018TranscriptPPT
-
Aug 2018Transcript PPT
-
Jul 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Jan 2018TranscriptPPT
-
Nov 2017Transcript PPT
-
Sep 2017Transcript PPT
-
Aug 2017TranscriptPPT
-
May 2017Transcript PPT
-
Feb 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
Jun 2016TranscriptPPT
-
May 2016Transcript PPT
-
Feb 2016Transcript PPT
Dabur India Limited is the fourth largest FMCG Company in India and the world’s largest Ayurvedic and Natural Health Care Company with a portfolio of over 250 Herbal/Ayurvedic products.[1]